The Fall 2019 issue of Brandeis Magazine features a cover story on Professor of Biochemistry and HHMI Investigator Dorothee Kern. The article describes Kern’s trajectory from her youth and education in the former East Germany to her current research and teaching at Brandeis to her co-founding of Relay Therapeutics, a Cambridge company pioneering new approaches to anti-cancer drug discovery.